| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,161,793 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$3,161,793 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -66.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-06-28 |
4 |
AS |
$10.01 |
$60,060 |
D/D |
(6,000) |
1,171 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-06-28 |
4 |
OE |
$5.80 |
$34,800 |
D/D |
6,000 |
7,171 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-03 |
4 |
AS |
$12.91 |
$77,460 |
D/D |
(6,000) |
1,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-03 |
4 |
OE |
$6.84 |
$41,040 |
D/D |
6,000 |
7,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-03-23 |
4 |
OE |
$14.47 |
$86,820 |
D/D |
6,000 |
8,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-03-23 |
4 |
AS |
$69.80 |
$420,020 |
D/D |
(6,000) |
7,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,195 |
15,411 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-22 |
4 |
AS |
$10.52 |
$65,224 |
D/D |
(6,200) |
561 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-22 |
4 |
OE |
$9.63 |
$59,675 |
D/D |
6,200 |
6,761 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-20 |
4 |
S |
$49.64 |
$322,643 |
D/D |
(6,500) |
65,754 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-20 |
4 |
OE |
$47.34 |
$307,710 |
D/D |
6,500 |
72,254 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,663 |
21,810 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2022-01-18 |
4 |
D |
$30.12 |
$202,587 |
D/D |
(6,726) |
54,887 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$340,063 |
D/D |
(6,745) |
77,323 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-01-18 |
4 |
S |
$38.89 |
$271,356 |
D/D |
(6,978) |
67,855 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-14 |
4 |
OE |
$6.25 |
$43,750 |
D/D |
7,000 |
7,537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-14 |
4 |
AS |
$19.26 |
$134,785 |
D/D |
(7,000) |
537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-02 |
4 |
OE |
$39.87 |
$281,203 |
D/D |
7,053 |
39,529 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-02 |
4 |
AS |
$51.32 |
$361,960 |
D/D |
(7,053) |
32,476 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-27 |
4 |
AS |
$10.42 |
$80,234 |
D/D |
(7,700) |
561 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-27 |
4 |
OE |
$9.63 |
$74,113 |
D/D |
7,700 |
8,261 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2019-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,822 |
27,218 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-04 |
4 |
AS |
$51.04 |
$405,615 |
D/D |
(7,947) |
32,476 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-04 |
4 |
OE |
$39.87 |
$316,847 |
D/D |
7,947 |
40,423 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-05-05 |
4 |
OE |
$5.80 |
$49,300 |
D/D |
8,500 |
8,839 |
|
- |
|
191 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
